Telephonic Contact and Subsequent Physical Follow up Treated Lung Cancer Patients (TELE001)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2011 by Tata Memorial Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Tata Memorial Hospital
ClinicalTrials.gov Identifier:
NCT01133067
First received: May 27, 2010
Last updated: June 16, 2011
Last verified: June 2011

May 27, 2010
June 16, 2011
July 2010
May 2012   (final data collection date for primary outcome measure)
Concurrence between the telephonic interview and the physician assessment [ Time Frame: 2 years ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01133067 on ClinicalTrials.gov Archive Site
  • Validation of the telephonic questionnaire grand score with the disease free and overall survival [ Time Frame: 2 years ] [ Designated as safety issue: No ]
  • Cost analysis [ Time Frame: 2 years ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Telephonic Contact and Subsequent Physical Follow up Treated Lung Cancer Patients
A Prospective Study of Telephonic Contact and Subsequent Physical Follow up of Radically Treated Lung Cancer Patients

Does the routine clinical practice of follow up after primary treatment in lung cancer patients has any utility.

Patients of cancer, after their primary treatment are subsequently called for follow up visits to assess the disease status. This has two important implications from the point of view of resource management. One, patients often have to travel long distances to report to the hospital and have to take care of other logistics such as their accommodation, local travel and food. Further often the patient travels with 1-2 attendants which adds to the logistic burden. Also, these patients of follow up also contribute to the load on existing hospital services. Many authors have speculated that follow-up visits generate anxiety about possible disease recurrence. On the other hand, many others have suggested that although there may be a transient increase in anxiety, patients are ultimately reassured by this practice. Hence, there is no firm evidence for the practice and the need for follow up in oncology care.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

All curative lung cancer patients after there intial primary treatment who have already been given scheduled appointment shall be called telephonically every 3 months. A set of questions shall be asked to the patient in his /her vernacular during the telephonic interview.After the telephonic interview, the patients shall then report to the cancer care specialist at the Hospital for the due follow up visit.

Lung Cancer
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
200
August 2012
May 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. All patients of lung cancer treated with a radical aim (e.g surgery, Chemoradiation, surgery followed by adjuvant treatment or any other combination)
  2. Patients should have completed radical /adjuvant treatment, if any
  3. Patients of both SCLC and NSCLC
  4. Patients with at least two telephone numbers (landline/mobile/both)
  5. Patients willing to participate

Exclusion Criteria:

  1. All patients for palliative intention
  2. Patients with less than two contact telephone numbers -
Both
18 Years to 90 Years
No
Contact: J P AGARWAL, MD +91 22 24177164 agarwaljp@tmc.gov.in
Contact: ANUSHEEL MUNSHI, MD +91 22 24177144 anusheel8@hotmail.com
India
 
NCT01133067
PROJECT NO 754
Yes
J P AGARWAL, TATA MEMORIAL HOSPITAL
Tata Memorial Hospital
Not Provided
Principal Investigator: JP AGARWAL, MD Tata Memorial Hospital
Tata Memorial Hospital
June 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP